WallStreetZenWallStreetZen

NASDAQ: KA
Kineta Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KA

Based on 1 analyst offering 12 month price targets for Kineta Inc.
Min Forecast
$8.00+1,159.84%
Avg Forecast
$8.00+1,159.84%
Max Forecast
$8.00+1,159.84%

Should I buy or sell KA stock?

Based on 1 analyst offering ratings for Kineta Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KA stock forecasts and price targets.

KA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-18

1 of 1

Forecast return on equity

Is KA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is KA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KA revenue forecast

What is KA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.2M-77.95%

KA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KA$0.64$8.00+1,159.84%Buy
TENX$3.56$30.00+742.70%Strong Buy
KTTA$6.76N/AN/A
TOVX$0.41N/AN/A
PSTV$1.66N/AN/A
View Top Biotech Stocks

Kineta Stock Forecast FAQ

Is Kineta Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KA) stock is to Buy KA stock.

Out of 1 analyst, 0 (0%) are recommending KA as a Strong Buy, 1 (100%) are recommending KA as a Buy, 0 (0%) are recommending KA as a Hold, 0 (0%) are recommending KA as a Sell, and 0 (0%) are recommending KA as a Strong Sell.

If you're new to stock investing, here's how to buy Kineta stock.

What is KA's revenue growth forecast for 2024-2024?

(NASDAQ: KA) Kineta's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Kineta's revenue in 2024 is $5,442,000.

In 2024, KA is forecast to generate $13,154,952 in revenue, with the lowest revenue forecast at $13,154,952 and the highest revenue forecast at $13,154,952.

What is KA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KA price target, the average KA price target is $8.00, with the highest KA stock price forecast at $8.00 and the lowest KA stock price forecast at $8.00.

The Wall Street analyst predicted that Kineta's share price could reach $8.00 by Jan 18, 2025. The average Kineta stock price prediction forecasts a potential upside of 1,159.84% from the current KA share price of $0.64.

What is KA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.